Literature DB >> 1612777

The changing importance of prognostic factors in breast cancer during long-term follow-up.

P Lipponen1, S Aaltomaa, M Eskelinen, V M Kosma, S Marin, K Syrjänen.   

Abstract

A cohort of 464 breast-cancer patients were followed up for over 10 years and the clinical, histological and morphometric factors were related to survival within different time periods during follow-up. Tumor diameter, axillary lymph-node status (pN), tubule formation and the fraction of intraductal growth as determined from the primary tumor biopsy specimen had prognostic value up to 5 years. Histological grade, morphometric nuclear factors and the M/V index had only short-term prognostic value immediately after the primary therapy. In axillary lymph-node-negative (ANN) tumors tubule formation, intraductal growth, tumor necrosis and tumor diameter had prognostic value during the first 3 postoperative years. In axillary lymph-node-positive (ANP) tumors, tumor diameter, intraductal growth and tubule formation had long-term prognostic value whereas the M/V index had prognostic value only for 1 postoperative year. Tumor diameter, axillary lymph-node status, tubule formation and the proportion of intraductal growth also had independent long-term prognostic value in a multivariate analysis and accordingly these factors can categorize breast-cancer patients into prognostic groups after several years of follow-up. In contrast, mitotic frequency loses its prognostic power within 2 postoperative years, while morphometric nuclear factors and histological grade have no practical prognostic value after 1 year of follow-up.

Entities:  

Mesh:

Year:  1992        PMID: 1612777     DOI: 10.1002/ijc.2910510506

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

Review 2.  The changing role of pathology in breast cancer diagnosis and treatment.

Authors:  Anthony S-Y Leong; Zhengping Zhuang
Journal:  Pathobiology       Date:  2011-06-14       Impact factor: 4.342

3.  Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer.

Authors:  M Schmitt; C Thomssen; K Ulm; A Seiderer; N Harbeck; H Höfler; F Jänicke; H Graeff
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis.

Authors:  P Lipponen; H Ji; S Aaltomaa; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  Oral contraceptive use and the prognosis of breast cancer.

Authors:  I Schönborn; P Nischan; K Ebeling
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer.

Authors:  I Schönborn; W Zschiesche; C Minguillon; E Spitzer; M Möhner; K Ebeling; R Grosse
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.